Harmony Biosciences (HRMY)
(Delayed Data from NSDQ)
$33.55 USD
+0.72 (2.19%)
Updated Aug 7, 2024 04:00 PM ET
After-Market: $33.78 +0.23 (0.69%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth F Momentum B VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 37% (93 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.00 | 1.35 | 9.99 |
Current Quarter Estimate | 0.57 | 7.43 | 61.00 |
Year Ago Quarter Estimate | 0.63 | 0.12 | 54.84 |
Next Quarter Estimate | 0.52 | 7.81 | 63.00 |
Next Year Estimate | 3.47 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -15.96 | 16.40 | 15.67 |
Next Year | 93.85 | 9.60 | 11.34 |
Last 5 Years | NA | 0.70 | 8.10 |
Next 5 Years | 22.80 | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 17.20 | -2.18 |
Price/Book (MRQ) | 3.54 | 2.03 |
Price/Cash Flow (MRFY) | 12.86 | 16.15 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 17.53% | -22.37% |
Return on Equity (TTM) | 22.97% | -31.10% |
Debt to Equity (MRQ) | 0.32 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.